English
Swedish
Finnish
English
Swedish
Finnish
Consumers
Pharmacies
Pharmacy Services
Brands
Pharmaceutical Companies
Expert services
Business Intelligence
Clinical studies
Translations and language services
Medical information and Patient support
Pharmacovigilance
Medicine importing
Market Access
Sales and Marketing
Regulatory Affairs
Real World Evidence
Patient support
Medical Support services
Logistics services
Investors
Oriola as an Investment
Strategy and Targets
Key Figures
Oriola’s investments
Business Environment
Market Outlook
Acquisitions and Divestments
Analysts
Share information and Shareholders
Share Price Trends Tool
Total Return Calculator
Dividence Policy
Share Capital and Shares
Flagging Notifications
Consensus Estimates
Consensus Estimate chart
Conversion Right
Shareholders
Major Shareholders - shares
Major Shareholders - Votes
Silent Period
Financial Information
Key Figures
Long Term Targets
Latest Outlook
IFRS Principles
Investor Calendar
Investor Relations
Presentations
Recordings and videos
Financial Reports
Q3 2019
Q2 2019
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Annual Reports
Corporate Governance
Shareholder Meetings
AGM 2020
AGM 2019
AGM 2018
AGM 2017
AGM 2016
AGM 2015
AGM 2014
AGM 2013
AGM 2012
AGM 2011
Shareholders' Nomination Board
The Board of Directors
Diversity Policy
Members of the Board
Board Committees
President and CEO
Group Management Team
Remuneration Statement
External Audit
Internal Supervision and Internal Audit
Risks
Insider Register
Articles of Association
Shareholders' Agreements
Disclosure Policy
Corporate Governance Statement 2018
Media
Careers
Open Vacancies
About us
Sustainability
Materiality Assessment
Waste
Pharmaceutical transportation
Energy
Tax footprint
Pharmaceutical safety
Diversity
Oriola as an employer
Business secrets
Supply Chain Management
Regulatory compliance
History
Management
Strategy
Contact